BCM
Bridgeway Capital Management Portfolio holdings
AUM
$4.21B
1-Year Return
17.73%
This Quarter Return
+9.42%
1 Year Return
+17.73%
3 Year Return
+87.27%
5 Year Return
+258.36%
10 Year Return
+515.25%
AUM
$4.21B
AUM Growth
+$243M
(+6.1%)
Cap. Flow
+$15M
Cap. Flow
% of AUM
0.36%
Top 10 Holdings %
Top 10 Hldgs %
8.22%
Holding
1,288
New
116
Increased
426
Reduced
381
Closed
108
Top Buys
| 1 |
Netflix
NFLX
|
+$23.5M |
| 2 |
IBM
IBM
|
+$20.5M |
| 3 |
AbbVie
ABBV
|
+$20.4M |
| 4 |
Advanced Micro Devices
AMD
|
+$20.4M |
| 5 |
Palantir
PLTR
|
+$20.3M |
Top Sells
| 1 |
TTM Technologies
TTMI
|
+$19.8M |
| 2 |
Pfizer
PFE
|
+$19.1M |
| 3 |
Qualcomm
QCOM
|
+$19.1M |
| 4 |
Comcast
CMCSA
|
+$19.1M |
| 5 |
Intel
INTC
|
+$19.1M |
Sector Composition
| 1 | Financials | 28.39% |
| 2 | Consumer Discretionary | 12.55% |
| 3 | Technology | 11.6% |
| 4 | Industrials | 11.34% |
| 5 | Energy | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Grove Collaborative
GROV
$62.7M
| $77.1K | ﹤0.01% |
67,025
| – | – |
|
|
CTNM
1102
Contineum Therapeutics
CTNM
$351M
| $76.2K | ﹤0.01% |
+19,200
| New | +$76.2K |
|
1103
Educational Development Corp
EDUC
$9.36M
| $74.9K | ﹤0.01% |
56,300
| – | – |
|
1104
Fractyl Health
GUTS
$68.9M
| $73.7K | ﹤0.01% |
45,500
-20,000
| -31% | -$32.4K |
|
1105
Shattuck Labs
STTK
$96.3M
| $73.1K | ﹤0.01% |
92,300
+55,000
| +147% | +$43.5K |
|
1106
Aware
AWRE
$59M
| $72.2K | ﹤0.01% |
38,400
-25,000
| -39% | -$47K |
|
1107
Culp
CULP
$57.4M
| $71.9K | ﹤0.01% |
18,300
| – | – |
|
1108
Prelude Therapeutics
PRLD
$67.4M
| $71.6K | ﹤0.01% |
88,500
| – | – |
|
1109
Air Industries Group
AIRI
$15.6M
| $71.1K | ﹤0.01% |
21,151
| – | – |
|
1110
Tilly's
TLYS
$61.6M
| $70.6K | ﹤0.01% |
51,159
-36,888
| -42% | -$50.9K |
|
1111
Cabaletta Bio
CABA
$150M
| $69.4K | ﹤0.01% |
45,675
| – | – |
|
1112
US Energy Corp
USEG
$38.4M
| $68.4K | ﹤0.01% |
48,848
| – | – |
|
1113
Babcock & Wilcox
BW
$203M
| $68.3K | ﹤0.01% |
71,000
-161,600
| -69% | -$155K |
|
1114
Orchestra BioMed
OBIO
$146M
| $67K | ﹤0.01% |
+25,000
| New | +$67K |
|
1115
MEI Pharma
MEIP
$91.3M
| $66.4K | ﹤0.01% |
26,869
| – | – |
|
1116
Vince Holding
VNCE
$19.3M
| $65.2K | ﹤0.01% |
45,256
| – | – |
|
1117
MAIA Biotechnology
MAIA
$52.5M
| $64.8K | ﹤0.01% |
36,000
| – | – |
|
1118
KRONOS Worldwide
KRO
$724M
| $64.1K | ﹤0.01% |
10,331
-294
| -3% | -$1.82K |
|
1119
AN2 Therapeutics
ANTX
$31.7M
| $63.5K | ﹤0.01% |
59,900
| – | – |
|
1120
SIFCO Industries
SIF
$42.8M
| $62.2K | ﹤0.01% |
16,674
| – | – |
|
1121
Marygold Companies
MGLD
$45.3M
| $62.2K | ﹤0.01% |
79,767
| – | – |
|
1122
Tevogen Bio Holdings
TVGN
$174M
| $61.9K | ﹤0.01% |
+49,500
| New | +$61.9K |
|
1123
NanoViricides
NNVC
$23.5M
| $61.7K | ﹤0.01% |
44,039
| – | – |
|
1124
United States Antimony
UAMY
$574M
| $60.6K | ﹤0.01% |
27,800
| – | – |
|
|
OKUR
1125
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
$34.8M
| $59.8K | ﹤0.01% |
25,000
| – | – |
|